HansBiomed Corporation (KOSDAQ:042520)
South Korea · Delayed Price · Currency is KRW 19,100
-600 (-3.05%)
At close: Jul 27, 2026
HansBiomed Market Cap
HansBiomed has a market cap or net worth of 266.26 billion as of July 28, 2026. Its market cap has increased by 136.20% in one year.
Market Cap
266.26B
Enterprise Value
290.29B
Revenue
110.50B
Ranking
n/a
PE Ratio
n/a
Stock Price
19,100.00
ChartMarket Cap Chart
Since October 9, 2009, HansBiomed's market cap has increased from 49.00B to 266.26B, an increase of 443.33%. That is a compound annual growth rate of 10.59%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 27, 2026 | 272.39B | -27.89% |
| Dec 30, 2025 | 377.76B | 229.79% |
| Dec 30, 2024 | 114.55B | -39.92% |
| Dec 28, 2023 | 190.65B | 100.91% |
| Dec 29, 2022 | 94.89B | -16.49% |
| Dec 30, 2021 | 113.63B | -16.24% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Inventage Lab | 389.03B |
| Curocell | 370.75B |
| IntoCell | 291.43B |
| IMBiologics | 253.15B |
| S.Biomedics | 214.39B |
| Kangstem Biotech | 198.92B |
| curacle co.,ltd. | 184.07B |
| Genome & Company | 171.97B |